JP2011224009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011224009A5 JP2011224009A5 JP2011118610A JP2011118610A JP2011224009A5 JP 2011224009 A5 JP2011224009 A5 JP 2011224009A5 JP 2011118610 A JP2011118610 A JP 2011118610A JP 2011118610 A JP2011118610 A JP 2011118610A JP 2011224009 A5 JP2011224009 A5 JP 2011224009A5
- Authority
- JP
- Japan
- Prior art keywords
- medium
- stem cell
- avian
- serum
- vaccinia virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000271566 Aves Species 0.000 claims 24
- 210000000130 stem cell Anatomy 0.000 claims 19
- 238000000034 method Methods 0.000 claims 18
- 210000001161 mammalian embryo Anatomy 0.000 claims 15
- 239000003102 growth factor Substances 0.000 claims 12
- 108090000695 Cytokines Proteins 0.000 claims 11
- 102000004127 Cytokines Human genes 0.000 claims 11
- 239000002609 medium Substances 0.000 claims 10
- 210000001671 embryonic stem cell Anatomy 0.000 claims 9
- 241001183012 Modified Vaccinia Ankara virus Species 0.000 claims 8
- 241000700618 Vaccinia virus Species 0.000 claims 8
- 210000002966 serum Anatomy 0.000 claims 8
- 241000700605 Viruses Species 0.000 claims 7
- 230000001464 adherent effect Effects 0.000 claims 7
- 239000007640 basal medium Substances 0.000 claims 7
- 241000700629 Orthopoxvirus Species 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 6
- 238000012258 culturing Methods 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 239000000725 suspension Substances 0.000 claims 4
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 claims 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims 2
- 241000287828 Gallus gallus Species 0.000 claims 2
- HPFXACZRFJDURI-KTKRTIGZSA-N N-oleoylglycine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCC(O)=O HPFXACZRFJDURI-KTKRTIGZSA-N 0.000 claims 2
- -1 SSEA-3 Chemical compound 0.000 claims 2
- 108010017842 Telomerase Proteins 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000012679 serum free medium Substances 0.000 claims 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims 2
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 claims 1
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 claims 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 1
- 102000003815 Interleukin-11 Human genes 0.000 claims 1
- 108090000177 Interleukin-11 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims 1
- 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 claims 1
- 102100020880 Kit ligand Human genes 0.000 claims 1
- 101710177504 Kit ligand Proteins 0.000 claims 1
- 102100032352 Leukemia inhibitory factor Human genes 0.000 claims 1
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims 1
- 239000012980 RPMI-1640 medium Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 230000006037 cell lysis Effects 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 claims 1
- 235000020776 essential amino acid Nutrition 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 claims 1
- 230000003362 replicative effect Effects 0.000 claims 1
- 229940054269 sodium pyruvate Drugs 0.000 claims 1
- 230000001502 supplementing effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03291813A EP1500699A1 (en) | 2003-07-22 | 2003-07-22 | Production of vaccinia virus with adherent or non adherent avian cell lines |
| EP03291813.8 | 2003-07-22 | ||
| FR0314389 | 2003-12-09 | ||
| FR0314389 | 2003-12-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520937A Division JP4787156B2 (ja) | 2003-07-22 | 2004-07-22 | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011224009A JP2011224009A (ja) | 2011-11-10 |
| JP2011224009A5 true JP2011224009A5 (enExample) | 2012-08-09 |
| JP5416169B2 JP5416169B2 (ja) | 2014-02-12 |
Family
ID=34081825
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520937A Expired - Fee Related JP4787156B2 (ja) | 2003-07-22 | 2004-07-22 | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
| JP2011118610A Expired - Fee Related JP5416169B2 (ja) | 2003-07-22 | 2011-05-27 | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520937A Expired - Fee Related JP4787156B2 (ja) | 2003-07-22 | 2004-07-22 | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US7432101B2 (enExample) |
| EP (2) | EP1646715B1 (enExample) |
| JP (2) | JP4787156B2 (enExample) |
| KR (1) | KR101121971B1 (enExample) |
| AT (1) | ATE467678T1 (enExample) |
| AU (1) | AU2004257939B2 (enExample) |
| CA (1) | CA2531565C (enExample) |
| DE (1) | DE602004027141D1 (enExample) |
| DK (1) | DK1646715T3 (enExample) |
| ES (1) | ES2345820T3 (enExample) |
| PL (1) | PL1646715T3 (enExample) |
| PT (1) | PT1646715E (enExample) |
| SI (1) | SI1646715T1 (enExample) |
| WO (1) | WO2005007840A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7445924B2 (en) * | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
| FR2836924B1 (fr) | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| UA85543C2 (ru) * | 2002-09-05 | 2009-02-10 | Бавариан Нордик А/С | Способ культивирования первичных клеток и амплификации вирусов в условиях безсывороточной среды, композиция и ее применение, и способ лечения или вакцинации животных |
| JP4787156B2 (ja) * | 2003-07-22 | 2011-10-05 | ビバリス | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| AU2011253998B2 (en) * | 2005-04-11 | 2014-04-24 | Valneva | Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| FR2884255B1 (fr) * | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| FR2898909A1 (fr) | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Combinaison de marqueurs de cellules aviaires |
| WO2007135133A1 (en) * | 2006-05-19 | 2007-11-29 | Vivalis | Avian cell lines derived from primordial germ cells useful for the production of substances of interest |
| KR101082296B1 (ko) | 2006-06-20 | 2011-11-09 | 트랜스진 에스.에이. | 폭스바이러스 및 폭스바이러스 조성물 제조 방법 |
| EP2500417A1 (en) | 2006-08-09 | 2012-09-19 | Vivalis | Method of production of transgenic avian using embryonic stem cells |
| WO2008109674A2 (en) * | 2007-03-05 | 2008-09-12 | Caridianbct, Inc. | Cell expansion system and methods of use |
| EP1985305A1 (en) * | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
| US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
| CN101688182A (zh) | 2007-07-03 | 2010-03-31 | 特兰斯吉恩股份有限公司 | 永生化禽细胞系 |
| PL214884B1 (pl) * | 2008-09-29 | 2013-09-30 | Inst Immunologii I Terapii Doswiadczalnej Pan | Test ELISA do wykrywania w surowicy bydlecej przeciwcial przeciwko antygenowi powierzchniowemu gp51 BLV |
| EP2379598B1 (en) | 2009-01-19 | 2015-03-11 | Innate Pharma | Anti-kir3d antibodies |
| CA2750055A1 (en) * | 2009-02-06 | 2010-08-12 | Glaxosmithkline Biologicals S.A. | Method for purifying viruses using a density gradient |
| KR20120026526A (ko) | 2009-05-12 | 2012-03-19 | 트랜스진 에스.에이. | 불멸화 조류 세포주 및 그의 용도 |
| NZ603620A (en) | 2010-07-20 | 2015-01-30 | Bavarian Nordic As | Method for harvesting expression products |
| US10214722B2 (en) * | 2010-09-07 | 2019-02-26 | Technion Research & Development Foundation Limited | Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| EP2660316A1 (en) | 2012-05-02 | 2013-11-06 | Helmholtz-Zentrum für Infektionsforschung GmbH | Avian cell line and its use in production of protein |
| US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
| WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| US10077421B2 (en) | 2014-04-24 | 2018-09-18 | Terumo Bct, Inc. | Measuring flow rate |
| WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
| AU2015357225B2 (en) | 2014-12-01 | 2020-04-09 | Transgene Sa | Stable liquid vaccinia virus formulations |
| WO2016088243A1 (ja) * | 2014-12-05 | 2016-06-09 | 株式会社ニコン | 判定装置、観察システム、観察方法、そのプログラム、細胞の製造方法、および細胞 |
| WO2016128542A1 (en) | 2015-02-13 | 2016-08-18 | Transgene Sa | Immunotherapeutic vaccine and antibody combination therapy |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| EP3452081A1 (en) | 2016-05-04 | 2019-03-13 | Transgene SA | Combination therapy with cpg tlr9 ligand |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| JP7406377B2 (ja) | 2017-05-15 | 2023-12-27 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 安定なウイルス含有組成物 |
| US11306292B2 (en) | 2017-05-15 | 2022-04-19 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
| KR102684237B1 (ko) | 2017-06-21 | 2024-07-11 | 트랜스진 | 개인 맞춤형 백신 |
| MX2020012895A (es) | 2018-05-30 | 2021-05-27 | Inst Res Biomedicine | Modificacion de linfocitos b al utilizar citidina desaminasa inducida por activacion endogena. |
| CA3111273C (en) | 2018-09-06 | 2024-03-26 | Bavarian Nordic A/S | Storage improved poxvirus compositions |
| KR20210094554A (ko) | 2018-11-23 | 2021-07-29 | 발네바 에스이 | 조류 줄기 세포를 포함하는 식품 |
| CN113227354A (zh) * | 2019-01-17 | 2021-08-06 | 勃林格殷格翰动物保健美国公司 | 用于禽类疫苗生产的无血清培养基及其用途 |
| JP7712284B2 (ja) | 2020-03-12 | 2025-07-23 | バヴァリアン・ノルディック・アクティーゼルスカブ | ポックスウイルスの安定性を改善する組成物 |
| CA3183701A1 (en) * | 2020-06-22 | 2021-12-30 | Sung Jin Kim | Method for large scale-production of vaccinia virus using suspension cells |
| TW202217002A (zh) | 2020-07-13 | 2022-05-01 | 法商傳斯堅公司 | 免疫抑制之治療 |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
| FR2726003B1 (fr) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| US5989805A (en) * | 1995-10-27 | 1999-11-23 | Board Of Trustees Operating Michigan State University | Immortal avian cell line to grow avian and animal viruses to produce vaccines |
| US5672485A (en) | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
| PT841392E (pt) | 1996-11-12 | 2004-11-30 | Univ Auburn | Vacina viva atenuada de neospora |
| DE60302654T2 (de) * | 2002-02-19 | 2006-09-14 | Cellergy Ltd. | Elektrochemischer kondensator und dessen herstellung |
| FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| CA2510229A1 (en) * | 2002-12-13 | 2004-07-08 | Aventis Pasteur, Inc. | Production of alvac on avian embryonic stem cells |
| JP4787156B2 (ja) * | 2003-07-22 | 2011-10-05 | ビバリス | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 |
| EP1528101A1 (en) * | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
-
2004
- 2004-07-22 JP JP2006520937A patent/JP4787156B2/ja not_active Expired - Fee Related
- 2004-07-22 CA CA2531565A patent/CA2531565C/en not_active Expired - Fee Related
- 2004-07-22 WO PCT/IB2004/002621 patent/WO2005007840A1/en not_active Ceased
- 2004-07-22 EP EP04744255A patent/EP1646715B1/en not_active Expired - Lifetime
- 2004-07-22 ES ES04744255T patent/ES2345820T3/es not_active Expired - Lifetime
- 2004-07-22 PT PT04744255T patent/PT1646715E/pt unknown
- 2004-07-22 AT AT04744255T patent/ATE467678T1/de active
- 2004-07-22 DE DE602004027141T patent/DE602004027141D1/de not_active Expired - Lifetime
- 2004-07-22 AU AU2004257939A patent/AU2004257939B2/en not_active Ceased
- 2004-07-22 SI SI200431453T patent/SI1646715T1/sl unknown
- 2004-07-22 US US10/565,281 patent/US7432101B2/en not_active Expired - Fee Related
- 2004-07-22 PL PL04744255T patent/PL1646715T3/pl unknown
- 2004-07-22 DK DK04744255.3T patent/DK1646715T3/da active
- 2004-07-22 KR KR1020067001289A patent/KR101121971B1/ko not_active Expired - Fee Related
- 2004-07-22 EP EP09174819A patent/EP2143788A1/en not_active Withdrawn
-
2008
- 2008-10-01 US US12/243,437 patent/US7771980B2/en not_active Expired - Fee Related
-
2009
- 2009-11-03 US US12/611,806 patent/US20100111999A1/en not_active Abandoned
-
2011
- 2011-05-27 JP JP2011118610A patent/JP5416169B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011224009A5 (enExample) | ||
| JP2006527995A5 (enExample) | ||
| JP4787156B2 (ja) | 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 | |
| US9822345B2 (en) | Method of making a virus using duck embryonic derived stem cell lines | |
| JP5031726B2 (ja) | 懸濁鳥類胚性幹細胞株においてウイルスワクチンを製造する方法 | |
| JP2012110344A5 (enExample) | ||
| CN1826406A (zh) | 用附着或非附着鸟细胞系生产痘病毒 | |
| CN100455661C (zh) | 一种禽类精原干细胞的体外培养方法 | |
| Hussain et al. | Adaptation of an indigenous very virulent infectious bursal disease virus on Vero cell line. | |
| Martin et al. | How to limit the use of serum in viral processes: A gibco perspective | |
| SUHAIROSLINDA-HAYATI | ADAPTATION OF INFECTIOUS BRONCHITIS VIRUS IN MAMMALIAN CELL LINE MJ SUHAIROSLINDA-HAYATI1, M. HAIR-BEJO1, 2, SS ARSHAD1 and AR OMAR1, 2 | |
| AU2011253998A1 (en) | Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |